| Date | Form | Description | Docs | XBRL | Pages |
| 01/06/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/06/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/22/13 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act |
|
6 | |
| 11/14/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/13/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/13/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/13/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/13/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/13/13 | 8-K | Current report filing |
|
8 | |
| 10/16/13 | 8-K | Current report filing |
|
4 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...